His scientific interests lie mostly in Cell biology, Antigen, Immunology, Immune system and Innate immune system. His Signal transduction study in the realm of Cell biology connects with subjects such as Population. His research in Signal transduction intersects with topics in Acquired immune system and Myeloid.
The Antigen study combines topics in areas such as Cytotoxic T cell, Cancer research and T cell. His Immunology research is multidisciplinary, incorporating perspectives in Transforming growth factor beta and In vitro. His study in Immune system is interdisciplinary in nature, drawing from both Confocal microscopy, Cell, Tetraspanin and Green fluorescent protein.
His primary scientific interests are in Cell biology, Immunology, Immune system, Antigen and Receptor. His Cell biology study combines topics in areas such as Chemokine, T cell, Cytotoxic T cell and Innate immune system. As part of his studies on Immunology, he often connects relevant areas like Interleukin 12.
His work carried out in the field of Antigen brings together such families of science as Cancer research, Immunotherapy, Cancer immunotherapy and Monoclonal antibody. His Receptor research includes themes of Myeloid, Inflammation, Programmed cell death and Bone marrow. His work in CD8 addresses issues such as Dendritic cell, which are connected to fields such as Syk.
David Sancho focuses on Cell biology, Immune system, Immunity, Dendritic cell and Immunology. His Cell biology research incorporates elements of Inflammation, Receptor, Chemokine and Chemokine receptor. His Immune system research is multidisciplinary, relying on both Cytokine, Antibody and Systemic inflammation.
His Immunity research is multidisciplinary, incorporating elements of Acquired immune system, Innate immune system and Nasal administration. Antigen, Myeloid and Proinflammatory cytokine are the primary areas of interest in his Immunology study. His work deals with themes such as Cancer research and Cancer immunotherapy, which intersect with Antigen.
David Sancho mainly focuses on Cell biology, Immune system, Immunity, Dendritic cell and T cell. The various areas that David Sancho examines in his Cell biology study include Chemokine, Receptor and CXCL2. His Immune system research entails a greater understanding of Immunology.
His work carried out in the field of Immunity brings together such families of science as Inflammation and Innate immune system. His biological study spans a wide range of topics, including Acquired immune system, Cytotoxic T cell, Sialoadhesin and Sialic acid binding. His study explores the link between Immunotherapy and topics such as Myeloid that cross with problems in Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dendritic cells in cancer immunology and immunotherapy.
Stefanie K Wculek;Francisco J Cueto;Adriana M Mujal;Ignacio Melero.
Nature Reviews Immunology (2020)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho;Olivier P Joffre;Anna M. Keller;Neil C. Rogers.
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.
Lionel Franz Poulin;Mariolina Salio;Emmanuel Griessinger;Fernando Anjos-Afonso.
Journal of Experimental Medicine (2010)
Myeloid C-type lectins in innate immunity
Matthew J. Robinson;David Sancho;Emma Wetter Slack;Salomé LeibundGut-Landmann.
Nature Immunology (2006)
CD69 is an immunoregulatory molecule induced following activation.
David Sancho;Manuel Gómez;Francisco Sánchez-Madrid.
Trends in Immunology (2005)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho;Diego Mourão-Sá;Olivier P. Joffre;Oliver Schulz.
Journal of Clinical Investigation (2008)
Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis
David Sancho;Caetano Reis e Sousa.
Annual Review of Immunology (2012)
F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells
Susan Ahrens;Santiago Zelenay;David Sancho;Pavel Hanč.
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sánchez-Paulete;Francisco J. Cueto;María Martínez-López;Sara Labiano.
Cancer Discovery (2016)
Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis
Marta Nieto;José M.R. Frade;David Sancho;Mario Mellado.
Journal of Experimental Medicine (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: